The Clinical Practice Innovation Award is given to members who devote the majority of their time to patient care and who have significantly advanced the clinical practice of infectious diseases within the last five years. This may be accomplished through innovation in clinical practice design or management, or advocacy on behalf of IDSA that fosters change to better recognize the value of infectious diseases practice.
2023 Winner: Dr. Jacinda Abdul-Mutakabbir
Dr. Jacinda Abdul-Mutakabbir, is currently an Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences as well as the Division of the Black Diaspora and African American Studies. Her clinical and research focus is centered on antimicrobial resistance and stewardship, where she identifies disparities and further explores the utility of preventative therapeutics in narrowing health equity gaps.
At the height of the COVID-19 pandemic, and in partnership with the Congregations Organized for Prophetic Engagement (COPE), Dr. Abdul-Mutakabbir developed a “Three-tiered” community-academic collaborative model aimed toward increasing COVID-19 vaccine uptake within San Bernardino County, CA Black communities. The three tiers included engaging Black Faith/Community Leaders (first tier), the provision of vaccine education from a Black pharmacist (second tier), and the placement of low-barrier vaccination clinics within Black communities (third tier). To date, this multifaceted approach has resulted in the vaccination of more than 3,500 individuals against COVID-19, with more than 85% of them identifying as a part of a racially/ethnically minoritized group. The findings from her community-based participatory research have been published in various journals including the Lancet Global Health and the Lancet Regional Health. Her expert opinion surrounding topics such as immunizations and improving uptake within minoritized communities have been featured in NPR, Scientific American, and US NEWS (among others).
Dr. Abdul-Mutakabbir also conducts translational research focused on identifying disparities in infectious diseases clinical outcomes. She has published several articles focused on identifying racial and social vulnerability differences in various infectious disease states, including Clostridium difficile infection, candidemia, and others. Additionally, she has presented both nationally and internationally on topics focused on prioritizing equity throughout antimicrobial stewardship programs and associated efforts.
Her dedication to improving public health has been recognized by the United States Public Health Services, as she was the 2017 recipient of the USPHS Outstanding Service Award, and she currently serves as an appointed member of the CVSH Health Equity National Advisory Board. She was also the 2021 recipient of the Society of Infectious Disease Gita Patel Best Practice Award, the awardee of the 2022 American Pharmacists Association-Immunization Champion (Honorable Mention) award, the 2021 recipient of the Wayne State University Warrior of Distinction of Alumni Award and was named a 30 under 30 Scientist by ECCMID at their 2021 31st annual meeting. Dr. Abdul-Mutakabbir continues to be an active member of several professional organizations including the American Society of Microbiology (ASM), the Infectious Diseases Society of America (IDSA), and the Society for Healthcare Epidemiology of America (SHEA).
Past Clinical Practice Innovation Award Winners
|2022||Nada Fadul, MD, FIDSA|
|2021||Erin K. McCreary, PharmD, BCPS, BCIDP and Vera Luther, MD, FIDSA|
|2020||Raghavendra Tirupathi, M.D.|
|2019||No Award Recipient|
|2018||Javeed Siddiqui, MD, MPH|
|2017||Kavita P. Bhavan, MD, MHS, FIDSA|